GENE MAPPING/ISOLATION BY CHROMOSOME TRANSFER AND POSITIONAL CLONING
GENE MAPPING/ISOLATION BY CHROMOSOME TRANSFER AND POSITIONAL CLONING
批准号:
6242184
负责人:
Markus Grompe
金额:
$25.92万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-07-01 至 1998-06-30
关键词:
DNA repair animal genetic material tag autosomal recessive trait cell fusion chemical cleavage chromosome deletion clone cells complementary DNA congenital aplastic anemia family genetics gene complementation genetic disorder diagnosis genetic mapping human genetic material tag linkage mapping molecular cloning molecular genetics polymerase chain reaction subtraction hybridization
中文摘要
克隆新的FA基因有几种可能的策略。Cdna
DNA交联型超敏反应的互补作用
导致了一个FA基因的克隆。然而,这种方法是有限的。
根据两个因素:a)cdna必须相对较小,b)适当
基因的调节表达不一定是细胞生存所必需的。
分离FA基因的另一种方法是定位克隆。到期
事实上,存在着多个互补小组,而且
家系的数量相对有限,FA基因的定位通过
单靠遗传连锁研究似乎很困难
我们建议使用染色体转移来定位FA的位置
总水平的基因,其次是遗传连锁和物理作图
进一步细化染色体位置,并最终克隆
基因。
标记了0418抗性基因的人类染色体将被
转移到FA患者转化的成纤维细胞中,
已知不代表互补C组。用DNA进行选择
交联剂将识别互补克隆和染色体
赋予抵抗力量的身份将被确定。更正的大小
在这种方法中,cDNAs是不相关的,并且适当地调节基因在
文中还提出了问题。一旦一条互补的染色体
确定后,FA基因的定位就越准确
体细胞杂交种的缺失作图鉴定及遗传
联动。现有的标记以及由染色体产生的新标记
将使用显微解剖和聚合酶链式反应进行遗传图谱的绘制。这一步
之后是将YAC与关键区域物理隔离
表达序列的作图和克隆。候选的cDNA将是
通过化学错配裂解筛选可能的突变。
要使用的另一种方法是识别鼠标
染色体携带如上所述的FA基因。补充FA细胞
小鼠的DNA可用于制备消减文库和
FA候选基因的直接克隆。
英文摘要
Several possible strategies for the cloning of new FA genes exist. cDNA
complementation of the DNA cross-linking hypersensitivity has already
resulted in the cloning of one FA gene. This method, however, is limited
by 2 factors: a) the cDNA has to be relatively small and b) properly
regulated expression of the gene must not he essential for cell survival.
An alternative method for isolating FA genes is positional cloning. Due
to the fact, that multiple complementation groups exist and that the
number of families is relatively limited, the mapping of the FA genes by
genetic linkage studies alone appears difficult
We here propose to use chromosome transfer to map the location of FA
genes at a gross level, followed by genetic linkage and physical mapping
to further refine the chromosomal position and to ultimately clone the
genes.
Human chromosomes marked with the 0418 resistance gene will be
transferred into transformed fibroblasts from FA patients, which are
known to not represent complementation group C. Selection with DNA
crosslinking agents will identify complemented clones and the chromosome
conferring the resistance will be identified. The size of the correcting
cDNA is not relevant in this method and proper regulation of the gene in
question is also given. Once a complementing chromosome has been
identified, the more precise localization of the FA gene will be
identified by deletion mapping in somatic cell hybrids and genetic
linkage. Existing markers as well as new markers generated by chromosome
microdissection and PCR will be employed for genetic mapping. This step
will be followed by isolation of YACs from the critical region, physical
mapping and the cloning of expressed sequences. Candidate cDNAs will be
screened by chemical mismatch cleavage for possible mutations.
An additional approach to be used is the identification of mouse
chromosomes bearing FA genes as described above. FA cells complemented
by mouse DNA could then be used to prepare subtractive cDNA libraries and
direct cloning of FA candidate cDNAs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
In vivo selection of gene modified hepatocytes
-
批准号:10623157
-
项目类别:
-
资助金额:$49.51万
-
财政年份:2021
-
负责人:Markus Grompe
-
依托单位:
In vivo selection of gene modified hepatocytes
-
批准号:10378002
-
项目类别:
-
资助金额:$49.51万
-
财政年份:2021
-
负责人:Markus Grompe
-
依托单位:
In vivo selection of gene modified hepatocytes
-
批准号:10209238
-
项目类别:
-
资助金额:$49.51万
-
财政年份:2021
-
负责人:Markus Grompe
-
依托单位:
Gene Therapy for Diabetes
-
批准号:10450678
-
项目类别:
-
资助金额:$69.94万
-
财政年份:2019
-
负责人:Markus Grompe
-
依托单位:
Gene Therapy for Diabetes
-
批准号:10239013
-
项目类别:
-
资助金额:$72.09万
-
财政年份:2019
-
负责人:Markus Grompe
-
依托单位:
Gene Therapy for Diabetes
-
批准号:10017960
-
项目类别:
-
资助金额:$72.91万
-
财政年份:2019
-
负责人:Markus Grompe
-
依托单位:
Liver Cancer Risk with rAAV Gene Therapy
-
批准号:9233058
-
项目类别:
-
资助金额:$58.59万
-
财政年份:2015
-
负责人:Markus Grompe
-
依托单位:
Liver Cancer Risk with rAAV Gene Therapy
-
批准号:9043838
-
项目类别:
-
资助金额:$63.66万
-
财政年份:2015
-
负责人:Markus Grompe
-
依托单位:
Liver Cancer Risk with rAAV Gene Therapy
-
批准号:8912920
-
项目类别:
-
资助金额:$60.81万
-
财政年份:2015
-
负责人:Markus Grompe
-
依托单位:
In vivo targeting of diabetes-relevant human cell types with rAAV vectors
-
批准号:8812513
-
项目类别:
-
资助金额:$360.47万
-
财政年份:2014
-
负责人:Markus Grompe
-
依托单位:
preclinical Testing of Novel Therapies in FA
-
批准号:8255537
-
项目类别:
-
资助金额:$30.17万
-
财政年份:2011
-
负责人:Markus Grompe
-
依托单位:
Cell Repository
-
批准号:8255541
-
项目类别:
-
资助金额:$30.17万
-
财政年份:2011
-
负责人:Markus Grompe
-
依托单位:
Administrative Core
-
批准号:8255542
-
项目类别:
-
资助金额:$30.17万
-
财政年份:2011
-
负责人:Markus Grompe
-
依托单位:
Novel Sources of Transplantable Beta-cell Replacements
-
批准号:8522279
-
项目类别:
-
资助金额:$132.69万
-
财政年份:2010
-
负责人:Markus Grompe
-
依托单位:
In Vivo Expansion of Human Hepatocytes in FRG Mice
-
批准号:8290314
-
项目类别:
-
资助金额:$31.79万
-
财政年份:2010
-
负责人:Markus Grompe
-
依托单位:
Novel Sources of Transplantable Beta-cell Replacements
-
批准号:8316306
-
项目类别:
-
资助金额:$137.52万
-
财政年份:2010
-
负责人:Markus Grompe
-
依托单位:
Novel Sources of Transplantable Beta-cell Replacements
-
批准号:8908448
-
项目类别:
-
资助金额:$28.74万
-
财政年份:2010
-
负责人:Markus Grompe
-
依托单位:
In Vivo Expansion of Human Hepatocytes in FRG Mice
-
批准号:8537528
-
项目类别:
-
资助金额:$13.54万
-
财政年份:2010
-
负责人:Markus Grompe
-
依托单位:
Novel Sources of Transplantable Beta-cell Replacements
-
批准号:7994973
-
项目类别:
-
资助金额:$108.6万
-
财政年份:2010
-
负责人:Markus Grompe
-
依托单位:
Novel Sources of Transplantable Beta-cell Replacements
-
批准号:8143487
-
项目类别:
-
资助金额:$108.59万
-
财政年份:2010
-
负责人:Markus Grompe
-
依托单位: